Investment Thesis

Procter & Gamble (PG) is a BUY at current prices due to its strong brand portfolio and resilient demand for essential consumer products. The market is underestimating the company's ability to sustain profit margins and market share amidst inflationary pressures and competitive dynamics. With a diversified product lineup and robust operational efficiency, PG is well-positioned to navigate market volatility and deliver consistent returns.

Competitive Moat

is durable over the next 5-10 years, supported by P&G's commitment to innovation and marketing. The primary threats include private label competition, which is increasingly gaining traction in the low-cost segment, and disruptive entrants that leverage e-commerce to capture market share.

Growth Engine

Future revenue growth for PG will primarily stem from innovation in product formulations, geographic expansion into emerging markets, and a focus on e-commerce channels. The total addressable market (TAM) for health and hygiene products continues to expand, particularly post-pandemic, as consumers prioritize health and wellness in their purchasing decisions. PG’s pricing power remains robust, allowing it to pass on costs effectively without sacrificing demand. The company is currently gaining market share in several segments, particularly in health care and beauty, driven by new product launches and strategic marketing efforts.